Reuters Health Report: Bristol-Myers to invest in Compugen, collaborate in clinical trials Newsletter

Bristol-Myers to invest in Compugen, collaborate in clinical trials

Bristol-Myers Squibb Co and Israel's Compugen said on Thursday they will collaborate in clinical trials for patients with advanced solid tumors.

Third African swine fever case in China's Liaoning province this week

A new outbreak of African swine fever has been detected in China's northeastern Liaoning province, the agriculture ministry said on Thursday, the province's third case this week.

Child refugees in Nauru camp struggle to eat, drink, talk: MSF

The mental health of refugees detained by Australia on the Pacific island of Nauru has deteriorated so badly that some children are in a "semi-comatose state", unable to eat, drink or talk, Médecins Sans Frontières (MSF) said on Thursday.

Nail polishes often claim falsely to be toxin-free

(Reuters Health) - Although nail polish manufacturers have begun removing some toxic ingredients, their labels are not always accurate and the reformulated products aren't necessarily safer, suggests a new study.

Irregular heart beat tied to increased risk for dementia

(Reuters Health) - Having a type of irregular heartbeat known as atrial fibrillation (AF) may raise an individual's risk of developing dementia, but treating AF with blood thinners seems to reduce that risk, researchers say.

Social media may reduce depression risk for older people with pain

(Reuters Health) - - Online socializing may weaken the tie between pain and depression for older people, a U.S. study suggests.

AcelRx shares surge after FDA staff says opioid safe

AcelRx Pharmaceuticals Inc's shares surged 30 percent on Wednesday after U.S. Food and Administration staff said the company's opioid treatment was safe and effective, bringing it one step closer to a marketing approval.

Top court rules against German certifier in French breast implant case

France's highest court threw out on Wednesday a 2015 ruling that cleared a German certifier of negligence after it approved faulty breast implants produced with counterfeit silicone.

LGBT youth at higher risk for suicide attempts

(This October 8 story has been refilled to correct "transsexual" to "transgender" in paragraph 3)

U.S. FDA panel backs Celltrion copycat of Roche blood cancer drug

Celltrion Pharm Inc's biosimilar of Roche Holding AG's blockbuster cancer drug, Rituxan, on Wednesday won unanimous backing from an advisory panel to the U.S. Food and Drug Administration.

FDA halts imports from China's Huahai Chuannan plant

(This 28 September story has been refilled as FDA spokesman corrects information to show import ban only applies to a single Huahai factory)

Related Videos

Boy band phenom BTS bring K-pop to London

After Swift gets political, voter registration surges

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS